Virus‐Based Nanoreactors with GALT Activity for Classic Galactosemia Therapy

On virus growth and form

(2020) Roya Zandi et al.   PHYSICS REPORTS-REVIEW SECTION OF PHYSICS LETTERS

Brome mosaic virus-like particles as siRNA nanocarriers for biomedical purposes

(2020) Alfredo Nuñez-Rivera et al.   Beilstein Journal of Nanotechnology

Vimentin as a Multifaceted Player and Potential Therapeutic Target in Viral Infections

(2020) Irene Ramos et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Protein Nanocage Architectures for the Delivery of Therapeutic Proteins

(2020) Yang Wang et al.   CURRENT OPINION IN COLLOID & INTERFACE SCIENCE

Protein cage assembly across multiple length scales

(2018) William M. Aumiller et al.   CHEMICAL SOCIETY REVIEWS

GALT Deficiency Galactosemia

(2018) Sharon Anderson   MCN-The American Journal of Maternal-Child Nursing

Hereditary galactosemia

(2018) Didem Demirbas et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Nephrotoxicity and Renal Pathophysiology: A Contemporary Perspective

(2018) Lillie M A Barnett et al.   TOXICOLOGICAL SCIENCES

Experimental and Theoretical Determination of the pH inside the Confinement of a Virus-Like Particle

(2018) Stan J. Maassen et al.   Small

Primary ovarian insufficiency in classic galactosemia: current understanding and future research opportunities

(2017) Mili Thakur et al.   JOURNAL OF ASSISTED REPRODUCTION AND GENETICS

Sweet and sour: an update on classic galactosemia

(2017) Ana I. Coelho et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Biomaterial-based nanoreactors, an alternative for enzyme delivery

(2017) Rina Koyani et al.   Nanotechnology Reviews

Remodeling of the fibroblast cytoskeletal architecture during the replication cycle of Ectromelia virus: A morphological in vitro study in a murine cell line

(2016) Lidia Szulc-Dabrowska et al.   Cytoskeleton

The molecular basis of galactosemia — Past, present and future

(2016) David J. Timson   GENE

Molecular basis of classic galactosemia from the structure of human galactose 1-phosphate uridylyltransferase

(2016) Thomas J. McCorvie et al.   HUMAN MOLECULAR GENETICS

International clinical guideline for the management of classical galactosemia: diagnosis, treatment, and follow-up

(2016) Lindsey Welling et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Dichloroacetate and Trichloroacetate Toxicity in AML12 Cells: Role of Oxidative Stress

(2015) Ezdihar Hassoun et al.   JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY

Segmented GFP-like aptamer probes for functional imaging of viral genome trafficking

(2015) Irina B. Tsvetkova et al.   VIRUS RESEARCH

Design of a VLP-nanovehicle for CYP450 enzymatic activity delivery

(2015) Lorena Sánchez-Sánchez et al.   JOURNAL OF NANOBIOTECHNOLOGY

Functional correction by antisense therapy of a splicing mutation in the GALT gene

(2014) Ana I Coelho et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

Cell Surface Vimentin Is an Attachment Receptor for Enterovirus 71

(2014) N. Du et al.   JOURNAL OF VIROLOGY

Synthetic and bioinspired cage nanoparticles for drug delivery

(2014) Stephanie Deshayes et al.   Nanomedicine

Virus-like particles as antigenic nanomaterials for inducing protective immune responses in the lung

(2014) Agnieszka Rynda-Apple et al.   Nanomedicine

Virus-based nanocarriers for drug delivery

(2012) Yujie Ma et al.   ADVANCED DRUG DELIVERY REVIEWS

Classical Galactosaemia in Ireland: incidence, complications and outcomes of treatment

(2012) K. P. Coss et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Diversity of approaches to classic galactosemia around the world: a comparison of diagnosis, intervention, and outcomes

(2012) Patricia P. Jumbo-Lucioni et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Galactosemia: When is it a newborn screening emergency?

(2012) Gerard T. Berry   MOLECULAR GENETICS AND METABOLISM

Endocytic Uptake Pathways Utilized by CPMV Nanoparticles

(2012) Emily M. Plummer et al.   MOLECULAR PHARMACEUTICS

Magnetic Virus-like Nanoparticles in N. benthamiana Plants: A New Paradigm for Environmental and Agronomic Biotechnological Research

(2011) Xinlei Huang et al.   ACS Nano

Optical Nano-Constructs Composed of Genome-Depleted Brome Mosaic Virus Doped with a Near Infrared Chromophore for Potential Biomedical Applications

(2011) Bongsu Jung et al.   ACS Nano

Genetically Programmed In Vivo Packaging of Protein Cargo and Its Controlled Release from Bacteriophage P22

(2011) Alison O'Neil et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Inborn errors of carbohydrate metabolism

(2011) Ertan Mayatepek et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

miR-30 inhibits TGF-β1-induced epithelial-to-mesenchymal transition in hepatocyte by targeting Snail1

(2011) Jingcheng Zhang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Applications of viral nanoparticles in medicine

(2011) Ibrahim Yildiz et al.   CURRENT OPINION IN BIOTECHNOLOGY

The adult galactosemic phenotype

(2011) Susan E. Waisbren et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Innovative therapy for Classic Galactosemia — Tale of two HTS

(2011) M. Tang et al.   MOLECULAR GENETICS AND METABOLISM

Cowpea mosaic virus nanoparticles target surface vimentin on cancer cells

(2011) Nicole F Steinmetz et al.   Nanomedicine

Japanese encephalitis virus interacts with vimentin to facilitate its entry into porcine kidney cell line

(2011) Soma Das et al.   VIRUS RESEARCH

Direct non-radioactive assay of galactose-1-phosphate:uridyltransferase activity using high performance liquid chromatography

(2010) Martijn Lindhout et al.   CLINICA CHIMICA ACTA

Catalytic capsids: the art of confinement

(2010) Inge J. Minten et al.   Chemical Science

Biomarkers of ovarian function in girls and women with classic galactosemia

(2008) Rebecca D. Sanders et al.   FERTILITY AND STERILITY